ArticleJournal of materials science. Materials in medicine2026
A self-healing hydrogel based on modified chitosan and sodium alginate oxide reinforced with hydrophilic nanomaterials for wound dressing applications.
Article in Journal of materials science. Materials in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
N-carboxyethyl chitosan (CECS) and sodium alginate oxide (SAO) are two biomaterials extensively used in tissue engineering, particularly in wound dressing (WD) applications. Nonetheless, these materials exhibit certain limitations such as inadequate physicomechanical properties, limited antibacterial activity in non-acidic environments, and insolubilityunder physiological condition. This study introduces an injectable self-healing hydrogel composed of CECS and SAO, improved with hydrophilic nanomaterials, i.e., cellulose nanofibers (CNFs) and copper oxide (CuO) nanoparticles, to address the inherent drawbacks of these hydrogels. The CECS/SAO/CNFs/CuO hydrogels were analyzed by varying the CNFs concentration (0, 0.05, 0.10, and 0.15 wt.%) and CuO nanoparticles content (0, 0.008, 0.020, 0.032 wt.%). Physicomechanical properties (compressive modulus and strength, % degradation, swelling, and pore size), rheological characteristics, and biological performance (assessed by fibroblast cell growth, adhesion, and live-dead tests) of the hydrogels were evaluated. The findings indicated that the CECS/SAO hydrogel containing 0.10% CNFs and 0.032% CuO nanoparticles exhibited appropriate physical properties (2259% swelling after 1 h, 22.3% degradation after 6 days, and 151 µm pore size), compressive modulus (22.31 kPa), shear thinning behavior, and biological viability (more than 90% after 3 days), while ensuring adequate injectability and proper self-healing. The antibacterial property of the hydrogel against Staphylococcus aureus and Escherichia coli was observed to be higher than 99.5%. These results highlight the significant potential of the CCH/SAO/CNFs/CuO hydrogel for wound dressing applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.